Multi4 is the world's first company to successfully develop automated technologies for the diagnosis and treatment of endoscopic cancer.
MULTI4 MEDICAL has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
MULTI4 MEDICAL's investors include Hans Cappelen Arnesen, Joachim Arcari, Per Langoe, Helena von Knorring, EIC Accelerator.
MULTI4 MEDICAL is headquartered in Mölndal, Sweden.
Multi4 is the world's first company to successfully develop automated technologies for the diagnosis and treatment of endoscopic cancer.
MULTI4 MEDICAL is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MULTI4 MEDICAL — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/multi4-medical. Accessed August 14, 2026.
VCBacked. (2026). MULTI4 MEDICAL — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/multi4-medical
{{cite web |title=MULTI4 MEDICAL — Funding & Investors |url=https://www.vcbacked.co/company/multi4-medical |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated